AMRN

Amarin Corp

17.32 USD
-0.01
0.06%
At close Jul 10, 4:00 PM EDT
1 day
-0.06%
5 days
4.59%
1 month
35.10%
3 months
91.81%
6 months
56.88%
Year to date
65.43%
1 year
14.17%
5 years
-87.11%
10 years
-64.07%
 

About: Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Employees: 275

0
Funds holding %
of 7,312 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

1,175% more call options, than puts

Call options by funds: $153K | Put options by funds: $12K

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]

0.43% less ownership

Funds ownership: 17.23% [Q4 2024] → 16.8% (-0.43%) [Q1 2025]

10% less capital invested

Capital invested by funds: $34.4M [Q4 2024] → $31.1M (-$3.3M) [Q1 2025]

12% less funds holding

Funds holding: 161 [Q4 2024] → 141 (-20) [Q1 2025]

26% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 38

56% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 27

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$12
31%
downside
Avg. target
$12
31%
downside
High target
$12
31%
downside

1 analyst rating

positive
0%
neutral
0%
negative
100%
Goldman Sachs
Paul Choi
31%downside
$12
Sell
Maintained
25 Jun 2025

Financial journalist opinion

Based on 7 articles about AMRN published over the past 30 days

Negative
Zacks Investment Research
1 week ago
Are Medical Stocks Lagging Amarin (AMRN) This Year?
Here is how Amarin (AMRN) and Abbott (ABT) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Amarin (AMRN) This Year?
Positive
Zacks Investment Research
1 week ago
Best Momentum Stock to Buy for June 27th
GTX, LPG and AMRN made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 27, 2025.
Best Momentum Stock to Buy for June 27th
Positive
Zacks Investment Research
2 weeks ago
Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU
AMRN jumps 27% after inking an exclusive EU licensing deal with Recordati to expand Vazkepa's reach and cut costs.
Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU
Positive
Zacks Investment Research
2 weeks ago
Amarin (AMRN) Soars 27.3%: Is Further Upside Left in the Stock?
Amarin (AMRN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Amarin (AMRN) Soars 27.3%: Is Further Upside Left in the Stock?
Neutral
GlobeNewsWire
2 weeks ago
RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE
RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA ® IN EUROPE
RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE
Positive
Zacks Investment Research
3 weeks ago
Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy?
From a technical perspective, Amarin Corporation PLC (AMRN) is looking like an interesting pick, as it just reached a key level of support. AMRN's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.
Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy?
Positive
Zacks Investment Research
3 weeks ago
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
Here is how Amarin (AMRN) and GSK (GSK) have performed compared to their sector so far this year.
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
Positive
Zacks Investment Research
4 weeks ago
Amarin (AMRN) Upgraded to Strong Buy: What Does It Mean for the Stock?
Amarin (AMRN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Amarin (AMRN) Upgraded to Strong Buy: What Does It Mean for the Stock?
Positive
Zacks Investment Research
1 month ago
Best Momentum Stocks to Buy for June 10th
AMRN, FIX and PATH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 10, 2025.
Best Momentum Stocks to Buy for June 10th
Positive
Zacks Investment Research
1 month ago
New Strong Buy Stocks for June 10th
FIX, GHLD, AMRN, VCISY and NWFL have been added to the Zacks Rank #1 (Strong Buy) List on June 10, 2025.
New Strong Buy Stocks for June 10th
Charts implemented using Lightweight Charts™